Molecular Biology Reports

, Volume 39, Issue 10, pp 9307–9310

Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome: formulation of an hypothesis

  • E. Urso
  • M. Agostini
  • S. Pucciarelli
  • C. Bedin
  • E. D’angelo
  • C. Mescoli
  • A. Viel
  • I. Maretto
  • I. Mammi
  • D. Nitti


Hereditary non-polyposis colorectal cancer (HNPCC) is a genetic disorder caused by mutation in one of the mismatch repair (MMR) genes (MLH1, MSH2, MSH6, PMS2) which predisposes to colorectal cancer and other malignances, that not yet include sarcomas. For sustaining that soft tissue sarcomas could be HNPCC related malignances, we report on a HNPCC patient with leiomyosarcoma and review the English literature. Overall, we report on eleven cases of soft tissue malignant tumors involving HNPCC patients, with a mean age of 34 years at diagnosis of sarcomas. In the majority of these tumors loss of MSH2 expression can be found at immunohistochemistry (IHC) and in 10 patients a germline mutation in one of the MMR genes was found (7 cases were MSH2 defective and 3 cases MLH1 defective). Data for supporting our hypothesis are also experimental, epidemiologic, histopathological: excess of sarcomas in PMS2 defective mice; sporadic soft tissue sarcomas are rare, with mean age at onset of 56 years and normal IHC for MMR proteins. In conclusion, the data collected support the hypothesis that soft tissue sarcomas could be included in the spectrum of tumors that, even if rarely, depend on MMR genes deficiency.


Sarcoma Hereditary non-polyposis colorectal cancer hMSH2 


  1. 1.
    Peltomaki P (2005) Lynch syndrome genes. Fam Cancer 4:227–232PubMedCrossRefGoogle Scholar
  2. 2.
    Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453–1456PubMedCrossRefGoogle Scholar
  3. 3.
    Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Lifetime risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430–433PubMedCrossRefGoogle Scholar
  4. 4.
    Lucci-Cordisco E, Zito I, Gensini F, Genuardi M (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet 122:325–334CrossRefGoogle Scholar
  5. 5.
    Agostini M, Tibiletti Mg, Lucci-Cordisco E et al (2005) Two PMS2 mutations in a Turcot syndromefamily with small bowel cancers. Am J Gastroenterol 100(8):1886–1891PubMedCrossRefGoogle Scholar
  6. 6.
    Umar A, Boland CR, Terdiman P et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRefGoogle Scholar
  7. 7.
    Agostini M, Enzo MV, Morandi L et al (2010) A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors. Cancer Biomark 6:49–61PubMedGoogle Scholar
  8. 8.
    Lindor NM, Burgart LJ, Leontovich O, Goldberg RM et al (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectaltumors. J Clin Oncol 20(4):1043–1048PubMedCrossRefGoogle Scholar
  9. 9.
    de Wind N, Dekker M, Claij N, Jansen L, van Klink Y, Radman M, Riggins G, van der Valk M, van’t Wout K, te Riele H (1999) HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat Genet 23:359–362PubMedCrossRefGoogle Scholar
  10. 10.
    Marra G, Iaccarino I, Lettieri T, Roscilli G, Delmastro P, Jiricny J (1998) Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci 95:8568–8573PubMedCrossRefGoogle Scholar
  11. 11.
    Chang DK, Ricciardiello L, Goel A, Chang CL, Boland R (2000) Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:18424–18431PubMedCrossRefGoogle Scholar
  12. 12.
    den Bakker MA, Seynaeve C, Kliffen M, Dinjens WNM (2003) Microsatellite instability in a pleomorphic rhabdomiosarcoma in a patient with hereditary non-polyposis colorectal cancer. Histopathology 43:297–299CrossRefGoogle Scholar
  13. 13.
    Medina Arana V, Barrios del Pino Y, Garcia-Castro C et al (2002) Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer. Ann Oncol 13:807–808PubMedCrossRefGoogle Scholar
  14. 14.
    Sijmons R, Hofstra R, Hollema H et al (2000) Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer. Genes Chromosomes Cancer 29:353–355PubMedCrossRefGoogle Scholar
  15. 15.
    Hirata K, Kanemitsu S, Nakayama Y et al (2006) HNPCC registry and genetic testing project of the Japanese Society for Cancer of the Colon and Rectum (JSCCR). A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. Am J Gastroenterol 101:193–196PubMedCrossRefGoogle Scholar
  16. 16.
    Nilbert M, Therkildsen C, Nissen A, Akerman M, Bernstein I (2009) Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum. Fam Cancer 8(3):209–213PubMedCrossRefGoogle Scholar
  17. 17.
    Brieger A, Engels K, Schaefer D, Plotz G, Zeuzem S, Raedle J, Trojan J (2011) Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families. Fam Cancer 10(3):591–595PubMedCrossRefGoogle Scholar
  18. 18.
    Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, Elliott EA, Yu J, Ashley T, Arnheim N, Flavell RA, Liskay RM (1995) Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82:309–319PubMedCrossRefGoogle Scholar
  19. 19.
    Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumour in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77:1836–1843PubMedCrossRefGoogle Scholar
  20. 20.
    Soravia C, van der Klift H, Brundler MA, Blouin JL, Wijnen J, Hutter P, Fodde R, Delozier-Blanchet C (2003) Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumour spectrum. Am J Med Genet 121:159–162CrossRefGoogle Scholar
  21. 21.
    Boyd J, Rhei E, Federici MG et al (1999) Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 53:87–91PubMedCrossRefGoogle Scholar
  22. 22.
    Broaddus RR, Lynch PM, Lu KH et al (2004) Unusual tumours associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol 17:981–989PubMedCrossRefGoogle Scholar
  23. 23.
    Kawaguchi K, Oda Y, Takahira T et al (2005) Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas. Oncol Rep 13:241–246PubMedGoogle Scholar
  24. 24.
    Surveillance Epidemiology and End Results (SEER) (2009) National Cancer Institute.
  25. 25.
    Kuismanen SA, Moisio AL, Schweizer P et al (2002) Endometrial and colorectal tumours from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am J Pathol 160:1953–1958PubMedCrossRefGoogle Scholar
  26. 26.
    Barnetson R, Jass J, Tse R et al (2000) Mutation associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoural heterogeneity. Genes Chromosomes Cancer 29:130–136PubMedCrossRefGoogle Scholar
  27. 27.
    Chao EC, Lipkin SM (2006) Molecular models for the tissue specificity of DNA mismatch repair deficient carcinogenesis. Nucleic Acids Res 34:840–852PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • E. Urso
    • 1
  • M. Agostini
    • 1
    • 2
  • S. Pucciarelli
    • 1
  • C. Bedin
    • 1
    • 3
  • E. D’angelo
    • 1
    • 3
  • C. Mescoli
    • 4
  • A. Viel
    • 5
  • I. Maretto
    • 1
  • I. Mammi
    • 1
  • D. Nitti
    • 1
  1. 1.Dipartimento di Scienze Chirurgiche, Oncologiche e GastroenterologicheClinica Chirurgica II, University of PadovaPaduaItaly
  2. 2.Department of NanomedicineThe Methodist Hospital Research InstituteHoustonUSA
  3. 3.Istituto Ricerca Pediatrica-Città della SperanzaPaduaItaly
  4. 4.II Servizio di Anatomia PatologicaIstituto Oncologico Veneto, IRCCPaduaItaly
  5. 5.Oncologia Sperimentale 1Centro Regionale OncologicoAvianoItaly

Personalised recommendations